GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » Cyclically Adjusted PS Ratio

Lushang Freda Pharmaceutical Co (SHSE:600223) Cyclically Adjusted PS Ratio : 0.86 (As of May. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-05-28), Lushang Freda Pharmaceutical Co's current share price is ¥7.98. Lushang Freda Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥9.32. Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 0.86.

The historical rank and industry rank for Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:600223' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.47   Med: 1.16   Max: 3.75
Current: 0.86

During the past years, Lushang Freda Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 3.75. The lowest was 0.47. And the median was 1.16.

SHSE:600223's Cyclically Adjusted PS Ratio is ranked better than
67.52% of 1370 companies
in the Real Estate industry
Industry Median: 1.725 vs SHSE:600223: 0.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥0.905. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥9.32 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lushang Freda Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lushang Freda Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 1.12 1.53 1.12 1.04

Lushang Freda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.08 0.93 1.04 0.91

Competitive Comparison of Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Lushang Freda Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=7.98/9.32
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lushang Freda Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Lushang Freda Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.905/115.2271*115.2271
=0.905

Current CPI (Mar. 2024) = 115.2271.

Lushang Freda Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.829 98.200 0.973
201409 1.712 98.900 1.995
201412 3.217 99.000 3.744
201503 0.835 99.900 0.963
201506 0.947 99.500 1.097
201509 0.429 100.500 0.492
201512 3.568 100.600 4.087
201603 1.138 102.200 1.283
201606 0.765 101.400 0.869
201609 1.872 102.400 2.106
201612 3.347 102.600 3.759
201703 0.776 103.200 0.866
201706 1.585 103.100 1.771
201709 1.391 104.100 1.540
201712 4.573 104.500 5.042
201803 0.904 105.300 0.989
201806 1.865 104.900 2.049
201809 2.964 106.600 3.204
201812 2.907 106.500 3.145
201903 1.291 107.700 1.381
201906 2.728 107.700 2.919
201909 2.881 109.800 3.023
201912 3.384 111.200 3.507
202003 1.349 112.300 1.384
202006 2.239 110.400 2.337
202009 3.428 111.700 3.536
202012 6.359 111.500 6.572
202103 1.689 112.662 1.727
202106 2.219 111.769 2.288
202109 2.255 112.215 2.316
202112 5.698 113.108 5.805
202203 1.341 114.335 1.351
202206 3.210 114.558 3.229
202209 3.408 115.339 3.405
202212 3.008 115.116 3.011
202303 1.279 115.116 1.280
202306 1.190 114.558 1.197
202309 0.838 115.339 0.837
202312 1.259 114.781 1.264
202403 0.905 115.227 0.905

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lushang Freda Pharmaceutical Co  (SHSE:600223) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Lushang Freda Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Traded in Other Exchanges
N/A
Address
No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
Executives
Li Hang senior management
Yin Wei Directors, senior managers
Shao Zhao Wei senior management
Wang Zhong Wu senior management
Dong Hong Lin Director
Zhou Hong Bo senior management
Li Lu senior management
Liu Zeng Wei senior management
Zhang Quan Li senior management
Xu Tao senior management
Ju Hai Bo Director
Zhao Xi Liang Director
Pi Xi Cai Supervisors

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines